These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8487154)

  • 1. Neonatal adaptation in hypertensive pregnancy--a study of labetalol vs hydralazine treatment.
    Hjertberg R; Faxelius G; Lagercrantz H
    J Perinat Med; 1993; 21(1):69-75. PubMed ID: 8487154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.
    Hjertberg R; Faxelius G; Belfrage P
    Acta Obstet Gynecol Scand; 1993 Nov; 72(8):611-5. PubMed ID: 8259746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of parenteral antihypertensive therapy for the treatment of severe maternal hypertension are low.
    Sharma KJ; Rodriguez M; Kilpatrick SJ; Greene N; Aghajanian P
    Hypertens Pregnancy; 2016; 35(1):123-8. PubMed ID: 26910380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of efficacy of intravenous labetalol and intravenous hydralazine for management of pre-eclampsia in pregnant women.
    Kausar M; Husain S; Hussain R
    Afr Health Sci; 2023 Mar; 23(1):320-325. PubMed ID: 37545898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial.
    S D; Novri DA; Hamidy Y; Savira M
    F1000Res; 2022; 11():1287. PubMed ID: 37273965
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol.
    Harper A; Murnaghan GA
    Br J Obstet Gynaecol; 1991 May; 98(5):453-9. PubMed ID: 2059591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
    Muhammad S; Usman H; Dawha YM; Yahya A; Yekeen A; Bako B
    Pregnancy Hypertens; 2022 Aug; 29():1-6. PubMed ID: 35605426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
    Heida KY; Zeeman GG; Van Veen TR; Hulzebos CV
    Early Hum Dev; 2012 Jul; 88(7):503-7. PubMed ID: 22525036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy.
    Mabie WC; Gonzalez AR; Sibai BM; Amon E
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):328-33. PubMed ID: 3306494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
    Hussein M; Mooij JM; Roujouleh H
    Kidney Blood Press Res; 2001; 24(2):124-8. PubMed ID: 11435745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial.
    Vigil-De Gracia P; Lasso M; Ruiz E; Vega-Malek JC; de Mena FT; López JC;
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):157-62. PubMed ID: 16621226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.
    Garden A; Davey DA; Dommisse J
    Clin Exp Hypertens B; 1982; 1(2-3):371-83. PubMed ID: 7139977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does labetalol predispose to pulmonary edema in severe pregnancy-induced hypertensive disease?
    Gilson GJ; Kramer RL; Barada C; Izquierdo LA; Curet LB
    J Matern Fetal Med; 1998; 7(3):142-7. PubMed ID: 9642612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversies Regarding Diagnosis and Treatment of Severe Hypertension in Pregnancy.
    Barton JR; Sibai BM
    Clin Obstet Gynecol; 2017 Mar; 60(1):198-205. PubMed ID: 28005594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Experiences of Intravenous Hydralazine and Labetalol for Acute Treatment of Severe Hypertension in Pregnant Thai Women.
    Chera-Aree P; Tengtrakulcharoen P; Leetheeragul J; Sampaojarean U; Surasereewong S; Wataganara T
    J Clin Pharmacol; 2020 Dec; 60(12):1662-1670. PubMed ID: 32598488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal hepatotoxicity induced by hydralazine or labetalol.
    Stumpf JL
    Pharmacotherapy; 1991; 11(5):415-8. PubMed ID: 1745625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term.
    Sibai BM; Gonzalez AR; Mabie WC; Moretti M
    Obstet Gynecol; 1987 Sep; 70(3 Pt 1):323-7. PubMed ID: 3627579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical efficacy and perinatal outcome of nifedipine for severe preeclampsia: meta-analysis].
    Liu QQ; Yu YH; Gong SP; Huang LP
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):592-7. PubMed ID: 23141179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hemodynamic effects of labetalol and hydralazine in the treatment of postoperative hypertension.
    Dimich I; Lingham R; Gabrielson G; Singh PP; Kaplan JA
    J Clin Anesth; 1989; 1(3):201-6. PubMed ID: 2627388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Molvi SN; Mir S; Rana VS; Jabeen F; Malik AR
    Arch Gynecol Obstet; 2012 Jun; 285(6):1553-62. PubMed ID: 22249781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.